[go: up one dir, main page]

RU93056633A - ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE - Google Patents

ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE

Info

Publication number
RU93056633A
RU93056633A RU93056633/14A RU93056633A RU93056633A RU 93056633 A RU93056633 A RU 93056633A RU 93056633/14 A RU93056633/14 A RU 93056633/14A RU 93056633 A RU93056633 A RU 93056633A RU 93056633 A RU93056633 A RU 93056633A
Authority
RU
Russia
Prior art keywords
nose
eyes
antiallergic composition
treatment
antiallergic
Prior art date
Application number
RU93056633/14A
Other languages
Russian (ru)
Other versions
RU2130774C1 (en
Inventor
Икедзири Есифуми
Огава Такахиро
Токумоти Фуминори
Самесима Сого
Кимура Мотоко
Original Assignee
Сендзю Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сендзю Фармасьютикал Ко., Лтд. filed Critical Сендзю Фармасьютикал Ко., Лтд.
Publication of RU93056633A publication Critical patent/RU93056633A/en
Application granted granted Critical
Publication of RU2130774C1 publication Critical patent/RU2130774C1/en

Links

Claims (1)

Раскрыта антиаллергическая композиция для лечения глаз и носа, в качестве активного ингредиента, включающая цетиризин или его соль. Кроме того, антиаллергическая композиция может содержать циклодекстриновое соединение, а также поверхностно-активное вещество и/или водорастворимый полимер.An antiallergic composition for treating eyes and nose is disclosed as an active ingredient comprising cetirizine or a salt thereof. In addition, the antiallergic composition may contain a cyclodextrin compound as well as a surfactant and / or a water-soluble polymer.
RU93056633A 1992-12-25 1993-12-24 Pharmaceutical composition for topical use for treatment of eye and nose allergic diseases RU2130774C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP346031/1992 1992-12-25
JP34603192 1992-12-25

Publications (2)

Publication Number Publication Date
RU93056633A true RU93056633A (en) 1997-01-10
RU2130774C1 RU2130774C1 (en) 1999-05-27

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93056633A RU2130774C1 (en) 1992-12-25 1993-12-24 Pharmaceutical composition for topical use for treatment of eye and nose allergic diseases

Country Status (23)

Country Link
US (1) US5419898A (en)
EP (1) EP0605203B1 (en)
JP (1) JP3683595B2 (en)
KR (1) KR100276743B1 (en)
CN (1) CN1050514C (en)
AT (1) ATE164068T1 (en)
AU (1) AU666413B2 (en)
BG (1) BG61101B1 (en)
CA (1) CA2112014C (en)
CZ (1) CZ283029B6 (en)
DE (1) DE69317537T2 (en)
DK (1) DK0605203T3 (en)
ES (1) ES2115733T3 (en)
FI (1) FI111805B (en)
HU (2) HU218672B (en)
LT (1) LT3344B (en)
LV (1) LV10688B (en)
NO (2) NO934630D0 (en)
NZ (1) NZ250519A (en)
PL (1) PL173347B1 (en)
RU (1) RU2130774C1 (en)
SK (1) SK279503B6 (en)
TW (1) TW401300B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216318C2 (en) * 1998-03-31 2003-11-20 Виатрис Гмбх Унд Ко. Кг. Solid rapidly decomposing carbonated composition of cetirizine for oral administration

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
AU714913B2 (en) * 1996-09-27 2000-01-13 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same
BE1011251A3 (en) * 1997-07-03 1999-06-01 Ucb Sa Pharmaceutical administrable oral, including an active substance and cyclodextrin.
EP0919550A1 (en) * 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
CA2342797A1 (en) 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
BR9804993A (en) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Antiallergic and anti-inflammatory composition
JP2001125052A (en) * 1999-10-25 2001-05-11 Lion Corp Contact lens mounting liquid
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
NZ534039A (en) * 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
PE20030729A1 (en) * 2002-01-18 2003-10-21 Novartis Ag METHODS FOR PRESERVING OPHTHALMIC SOLUTIONS AND PRESERVED OPHTHALMIC SOLUTIONS
JP4543274B2 (en) * 2002-10-01 2010-09-15 大正製薬株式会社 Nasal composition
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2624585T3 (en) * 2004-05-28 2017-07-17 Imaginot Pty Ltd. Oral therapeutic compound delivery system
JP2006008568A (en) * 2004-06-24 2006-01-12 Cyclochem:Kk IgE antibody inhibitor and food
PE20060484A1 (en) * 2004-07-14 2006-07-06 Ucb Farchim Sa LIQUID PHARMACEUTICAL PREPARATIONS CONTAINING A BENZHYDRIL PIPERIZINE COMPOUND
CA2574602A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
BRPI0610308A8 (en) 2005-05-26 2017-04-25 Neuron Systems Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DISEASE
JPWO2006137433A1 (en) * 2005-06-21 2009-01-22 わかもと製薬株式会社 Aqueous drug with solubilized levocabastine
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
BRPI0708891A2 (en) * 2006-03-13 2011-06-28 R Tech Ueno Ltd aqueous composition
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (en) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 Chinese medicinal composition for treating skin hypersensitivity disease
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
EP3943069B1 (en) * 2009-03-17 2024-11-27 Nicox Ophthalmics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8263581B2 (en) * 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
KR20120059545A (en) * 2009-08-12 2012-06-08 루난 베터 파마슈티칼 씨오., 엘티디 Pharmaceutical solution of cetirizine hydrochloride
BR112012010658A2 (en) 2009-11-06 2015-10-06 Univ Yale amphiphilic compositions and processes for their preparation and use
US9814701B2 (en) 2009-12-11 2017-11-14 Aldeyra Therapeutics, Inc. Compositions and methods for the treatment of macular degeneration
KR101922752B1 (en) 2011-11-29 2018-11-27 주록스 피티와이 리미티드 Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
CN105120866B (en) 2013-01-23 2020-02-14 奥尔德拉医疗公司 Diseases and treatments associated with toxic aldehydes
WO2017035077A1 (en) 2015-08-21 2017-03-02 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
CN109069530A (en) * 2016-02-28 2018-12-21 奥尔德拉医疗公司 Treating Allergic Eye Conditions with Cyclodextrins
CA3022665A1 (en) 2016-05-09 2017-11-16 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
JP6843896B2 (en) * 2017-02-13 2021-03-17 日東メディック株式会社 Aqueous eye drop nasal composition
CN110431130A (en) 2017-03-16 2019-11-08 奥尔德拉医疗公司 Polymorphic compounds and their uses
CN111356451A (en) 2017-10-10 2020-06-30 奥尔德拉医疗公司 Treatment of Inflammatory Conditions
DK3740191T3 (en) * 2018-01-18 2021-06-07 Faes Farma Sa Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent
US12006298B2 (en) 2018-08-06 2024-06-11 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US11197821B2 (en) 2018-09-25 2021-12-14 Aldeyra Therapeutics, Inc. Formulations for treatment of dry eye disease
JP7706758B2 (en) 2019-03-26 2025-07-14 アルデイラ セラピューティクス， インコーポレイテッド Ophthalmic preparations and uses thereof
EP3725298A1 (en) * 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
US12098132B2 (en) 2019-05-02 2024-09-24 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
CA3137301A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
EP4149470A4 (en) 2020-05-13 2024-04-24 Aldeyra Therapeutics, Inc. PHARMACEUTICAL FORMULATIONS AND USES THEREOF
CN120437087A (en) 2024-02-01 2025-08-08 科赴品牌有限责任公司 Orally dissolving film preparation, use thereof and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (en) * 1981-02-06 1989-05-22 Ucb Sa METHOD OF ANALOGUE FOR THE PREPARATION OF 2- (2- (4- (DIPHENYL-METHYL) -1-PIPERAZINYL) ETHOXY) -ACETAMIDES OR ACID ADDITION SALTS.
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
IT1246188B (en) * 1990-07-27 1994-11-16 Resa Farma PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING INCREASED SPEED OF DISSOLUTION OF THE ACTIVE SUBSTANCE AND COMPOSITIONS OBTAINED.
DE9015551U1 (en) * 1990-11-14 1992-03-12 Röhm GmbH, 6100 Darmstadt Oral dosage form and coating agent containing a colon-degradable polysaccharide
JPH06311353A (en) 1993-04-19 1994-11-04 Brother Ind Ltd Color image forming device
JP2619828B2 (en) 1996-06-17 1997-06-11 九州日立マクセル株式会社 Electric nail polish machine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216318C2 (en) * 1998-03-31 2003-11-20 Виатрис Гмбх Унд Ко. Кг. Solid rapidly decomposing carbonated composition of cetirizine for oral administration

Similar Documents

Publication Publication Date Title
RU93056633A (en) ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE
FI935851A0 (en) Antiallergic moss treatment For ophthalmic or nasal Bruk
EP0815860A3 (en) Terfenadine carboxylate and the treatment of allergic disorders
FI955315A0 (en) HIV protease inhibitors useful in the treatment of AIDS
ATE114113T1 (en) USE OF DROLOXIFEN IN THE TREATMENT OF BONE DISEASES.
EP0676954A4 (en) LURE OF HUMAN IMMUNODEFICIENCY VIRUS.
NO913136D0 (en) PREPARATION FOR EYE DRAWINGS.
RU95122135A (en) COMBINATION FOR PREVENTION AND TREATMENT OF AIDS, PHARMACEUTICAL COMPOSITION ON ITS BASIS
EP0158481A3 (en) Hair care compositions
EP0589047A4 (en) Method of treating infectious disease, method of preventing putrefaction of cosmetic, and antibacterial/antifungal agent and cosmetic.
CA2190303A1 (en) Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom
HUP9900361A2 (en) Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds
DE69106630D1 (en) Aqueous cosmetic composition and its manufacturing process.
RU93004781A (en) PSEVDEPEPTIDY, WAYS OF THEIR RECEPTION AND APPLICATION
RU94008619A (en) DERIVATIVES OF DIHYDROBENZOFURANE, HERBICID COMPOSITION AND METHOD FOR DESTROYING WEEDS
RU94011321A (en) METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES
RU94012554A (en) SHAMPOO, POSSESSING ANTI-PEDICULAR ACTION, ITS COMPOSITION AND METHOD OF MANUFACTURE
DE69524388D1 (en) 4-AMINO-6-SUBSTITUTED MYCOPHENOLIC ACID DERIVATIVES WITH IMMUNE-SUPPRESSIVE EFFECT
ATE168004T1 (en) ITCH RELIEF
CA2074503A1 (en) Pharmaceutical formulation containing penciclovir
RU93019277A (en) SOLUTION FOR THE PROTECTION AND TREATMENT OF DISEASES AND DAMAGE TO THE CORNICE VIZITON
IT1237084B (en) AWARENESS OF METALLORGANIC COMPOUNDS FOR PHOTOCATALIZED RADICAL POLYMERIZATION AND STABILIZATION OF THE PREPARATIONS.
RU96110609A (en) METHOD FOR TREATING POST-TRAUMATIC INNER-EYE INFECTION
RU98109064A (en) EYE FILMS
RU96113185A (en) SOLUTION FOR THE TREATMENT OF DISEASES AND DAMAGE TO KORATAN-S KORGANITSA